224 related articles for article (PubMed ID: 18430494)
1. Evaluation of ISCOM-adjuvanted subunit vaccines containing recombinant feline immunodeficiency virus Rev, OrfA and envelope protein in cats.
Huisman W; Schrauwen EJ; Pas SD; van Amerongen G; Rimmelzwaan GF; Osterhaus AD
Vaccine; 2008 May; 26(21):2553-61. PubMed ID: 18430494
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of vaccination strategies against infection with feline immunodeficiency virus (FIV) based on recombinant viral vectors expressing FIV Rev and OrfA.
Huisman W; Schrauwen EJ; Tijhaar E; Süzer Y; Pas SD; van Amerongen G; Sutter G; Rimmelzwaan GF; Osterhaus AD
Vet Immunol Immunopathol; 2008 Dec; 126(3-4):332-8. PubMed ID: 18952300
[TBL] [Abstract][Full Text] [Related]
3. Gag-specific immune enhancement of lentiviral infection after vaccination with an adenoviral vector in an animal model of AIDS.
Klonjkowski B; Klein D; Galea S; Gavard F; Monteil M; Duarte L; Fournier A; Sayon S; Górna K; Ertl R; Cordonnier N; Sonigo P; Eloit M; Richardson J
Vaccine; 2009 Feb; 27(6):928-39. PubMed ID: 19070641
[TBL] [Abstract][Full Text] [Related]
4. Should accessory proteins be structural components of lentiviral vaccines? Lessons learned from the accessory ORF-A protein of FIV.
Pistello M
Vet Immunol Immunopathol; 2008 May; 123(1-2):144-9. PubMed ID: 18304653
[TBL] [Abstract][Full Text] [Related]
5. Partial protection by vaccination with recombinant feline immunodeficiency virus surface glycoproteins.
Leutenegger CM; Hofmann-Lehmann R; Holznagel E; Cuisinier AM; Wolfensberger C; Duquesne V; Cronier J; Allenspach K; Aubert A; Ossent P; Lutz H
AIDS Res Hum Retroviruses; 1998 Feb; 14(3):275-83. PubMed ID: 9491919
[TBL] [Abstract][Full Text] [Related]
6. Protection of neonatal kittens against feline immunodeficiency virus infection with passive maternal antiviral antibodies.
Pu R; Okada S; Little ER; Xu B; Stoffs WV; Yamamoto JK
AIDS; 1995 Mar; 9(3):235-42. PubMed ID: 7755911
[TBL] [Abstract][Full Text] [Related]
7. Feline immunodeficiency virus subunit vaccines that induce virus neutralising antibodies but no protection against challenge infection.
Huisman W; Karlas JA; Siebelink KH; Huisman RC; de Ronde A; Francis MJ; Rimmelzwaan GF; Osterhaus AD
Vaccine; 1998; 16(2-3):181-7. PubMed ID: 9607028
[TBL] [Abstract][Full Text] [Related]
8. Pre-existing immunity to pathogenic Listeria monocytogenes does not prevent induction of immune responses to feline immunodeficiency virus by a novel recombinant Listeria monocytogenes vaccine.
Stevens R; Lavoy A; Nordone S; Burkhard M; Dean GA
Vaccine; 2005 Feb; 23(12):1479-90. PubMed ID: 15670884
[TBL] [Abstract][Full Text] [Related]
9. Env-specific CTL predominate in cats protected from feline immunodeficiency virus infection by vaccination.
Flynn JN; Keating P; Hosie MJ; Mackett M; Stephens EB; Beatty JA; Neil JC; Jarrett O
J Immunol; 1996 Oct; 157(8):3658-65. PubMed ID: 8871667
[TBL] [Abstract][Full Text] [Related]
10. Salmonella typhimurium aroA recombinants and immune-stimulating complexes as vaccine candidates for feline immunodeficiency virus.
Tijhaar EJ; Huisman W; Huisman RC; Siebelink KH; Karlas JA; de Ronde A; van Herwijnen R; Mooi FR; Osterhaus AD
J Gen Virol; 1997 Dec; 78 ( Pt 12)():3265-75. PubMed ID: 9400977
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of feline immunodeficiency virus infection after immunization with envelope glycoprotein subunit vaccines.
Siebelink KH; Tijhaar E; Huisman RC; Huisman W; de Ronde A; Darby IH; Francis MJ; Rimmelzwaan GF; Osterhaus AD
J Virol; 1995 Jun; 69(6):3704-11. PubMed ID: 7745719
[TBL] [Abstract][Full Text] [Related]
12. Enhancement after feline immunodeficiency virus vaccination.
Hosie MJ; Osborne R; Reid G; Neil JC; Jarrett O
Vet Immunol Immunopathol; 1992 Dec; 35(1-2):191-7. PubMed ID: 1337397
[TBL] [Abstract][Full Text] [Related]
13. Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.
Dean GA; LaVoy A; Burkhard MJ
Vet Immunol Immunopathol; 2004 Jul; 100(1-2):49-59. PubMed ID: 15182995
[TBL] [Abstract][Full Text] [Related]
14. Mutations in feline immunodeficiency (FIV) virus envelope gene V3-V5 regions in FIV-infected cats.
Motokawa K; Hohdatsu T; Imori A; Arai S; Koyama H
Vet Microbiol; 2005 Mar; 106(1-2):33-40. PubMed ID: 15737471
[TBL] [Abstract][Full Text] [Related]
15. Dual-subtype vaccine (Fel-O-Vax FIV) protects cats against contact challenge with heterologous subtype B FIV infected cats.
Kusuhara H; Hohdatsu T; Okumura M; Sato K; Suzuki Y; Motokawa K; Gemma T; Watanabe R; Huang C; Arai S; Koyama H
Vet Microbiol; 2005 Jul; 108(3-4):155-65. PubMed ID: 15899558
[TBL] [Abstract][Full Text] [Related]
16. MHC-restricted protection of cats against FIV infection by adoptive transfer of immune cells from FIV-vaccinated donors.
Pu R; Omori M; Okada S; Rine SL; Lewis BA; Lipton E; Yamamoto JK
Cell Immunol; 1999 Nov; 198(1):30-43. PubMed ID: 10612649
[TBL] [Abstract][Full Text] [Related]
17. Targeted lymph node immunization can protect cats from a mucosal challenge with feline immunodeficiency virus.
Finerty S; Stokes CR; Gruffydd-Jones TJ; Hillman TJ; Barr FJ; Harbour DA
Vaccine; 2001 Oct; 20(1-2):49-58. PubMed ID: 11567745
[TBL] [Abstract][Full Text] [Related]
18. Prime-boost vaccination using DNA and whole inactivated virus vaccines provides limited protection against virulent feline immunodeficiency virus.
Dunham SP; Bruce J; Klein D; Flynn JN; Golder MC; MacDonald S; Jarrett O; Neil JC
Vaccine; 2006 Nov; 24(49-50):7095-108. PubMed ID: 17049683
[TBL] [Abstract][Full Text] [Related]
19. Env-expressing autologous T lymphocytes induce neutralizing antibody and afford marked protection against feline immunodeficiency virus.
Pistello M; Bonci F; Zabogli E; Conti F; Freer G; Maggi F; Stevenson M; Bendinelli M
J Virol; 2010 Apr; 84(8):3845-56. PubMed ID: 20130057
[TBL] [Abstract][Full Text] [Related]
20. Dissection of seroreactivity against the tryptophan-rich motif of the feline immunodeficiency virus transmembrane glycoprotein.
Freer G; Giannecchini S; Tissot A; Bachmann MF; Rovero P; Serres PF; Bendinelli M
Virology; 2004 May; 322(2):360-9. PubMed ID: 15110533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
